BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8114950)

  • 1. The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats.
    Tao PL; Lee CR; Law PY; Loh HH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):504-8. PubMed ID: 8114950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the interaction of mu-opioid receptor and G protein after chronic PL017 treatment in rats.
    Tao PL; Lue WM; Lee CR; Chang LR
    Chin J Physiol; 1995; 38(3):193-9. PubMed ID: 8846729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
    Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
    Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAMGO-induced μ opioid receptor internalization and recycling restore morphine sensitivity in tolerant rat.
    Ma X; Chen R; Huang M; Wang W; Luo L; Kim DK; Jiang W; Xu T
    Eur J Pharmacol; 2020 Jul; 878():173118. PubMed ID: 32320702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment.
    Selley DE; Nestler EJ; Breivogel CS; Childers SR
    Brain Res; 1997 Jan; 746(1-2):10-8. PubMed ID: 9037478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I.
    Burford NT; Tolbert LM; Sadee W
    Eur J Pharmacol; 1998 Jan; 342(1):123-6. PubMed ID: 9544801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
    Tao PL; Tsai CL; Chang LR; Loh HH
    Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury.
    Porreca F; Tang QB; Bian D; Riedl M; Elde R; Lai J
    Brain Res; 1998 Jun; 795(1-2):197-203. PubMed ID: 9622629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
    Reddy PL; Veeranna ; Matwyshyn GA; Thorat SN; Bhargava HN
    Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception.
    Raffa RB; Martinez RP; Connelly CD
    Eur J Pharmacol; 1994 Jun; 258(1-2):R5-7. PubMed ID: 7925586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic evidence for decrease in binding of mu- and delta-opioid receptors after subchronic [D-Ala2,D-Leu5]enkephalin treatment in rats.
    Tao PL; Seybold VS; Loh HH
    Eur J Pharmacol; 1993 Feb; 231(2):145-9. PubMed ID: 8384111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat.
    Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
    Gen Pharmacol; 1993 Nov; 24(6):1351-7. PubMed ID: 8112506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
    Carter BD; Medzihradsky F
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
    Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
    Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.